UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002405 |
|---|---|
| Receipt number | R000002950 |
| Scientific Title | Photodynamic therapy with one third dose verteporfin for central serous chorioretinopathy:Prospective intervention trial |
| Date of disclosure of the study information | 2009/10/01 |
| Last modified on | 2014/05/17 17:03:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/08/30 23:35:51 | ||
| 2 | Update | 2009/09/23 19:50:35 | Key inclusion criteria Key exclusion criteria Target sample size |
|
| 3 | Update | 2009/09/26 10:28:42 | Recruitment status |
|
| 4 | Update | 2009/11/29 18:48:21 | Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2009/11/29 19:03:42 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2009/11/29 19:04:52 | Key inclusion criteria |
|
| 7 | Update | 2009/11/29 19:11:05 | Primary outcomes |
|
| 8 | Update | 2009/11/29 19:12:45 | Key secondary outcomes |
|
| 9 | Update | 2009/11/29 21:12:53 | Interventions/Control_1 Interventions/Control_1 |
|
| 10 | Update | 2009/11/29 21:13:47 | TEL TEL Institutions |
|
| 11 | Update | 2009/11/29 21:25:54 | Last follow-up date Date of closure to data entry |
|
| 12 | Update | 2010/01/03 12:45:18 | Key secondary outcomes Key secondary outcomes |
|
| 13 | Update | 2010/08/31 18:46:39 | Recruitment status |
|
| 14 | Update | 2011/08/30 17:21:23 | Recruitment status |
|
| 15 | Update | 2014/05/17 17:03:15 | Email Last name of contact person Last name of contact person Name of person sending information Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. |
